Omega-3 Pioneer to be Scientific Advisor to Cognis
Jorn Dyerberg, MD, Professor and Dr. Med.Sci., was a pioneer in both the discovery of omega-3 fatty acids in food, and of their considerable health benefits. His findings came in the 1970s, while studying the Greenland Inuit or Eskimo population.
26/04/07 Cognis has announced that Professor Jorn Dyerberg is to be its medical and scientific advisor for omega-3 fish oils. The group’s high purity range of Omevital omega-3 fish oils will make their Vitafoods International debut in Geneva this May.
Jorn Dyerberg, MD, Professor and Dr. Med.Sci., was a pioneer in both the discovery of omega-3 fatty acids in food, and of their considerable health benefits. His findings came in the 1970s, while studying the Greenland Inuit or Eskimo population. Professor Dyerberg, who is Danish, hypothesized that the rarity of coronary heart disease among the Inuit could be due to the omega-3 fatty acids found in their staple diet, based on cold-water oily fish. Together with his fellow countryman, Dr. Hans Olav Bang, he went on to demonstrate the unique physiological effects of these fatty acids. His work opened up a whole new field of medical research and, since then, thousands of studies have been published and many are currently in progress.
Petra Mueller, Global Product Line Manager for Cognis Nutrition & Health’s omega-3 range said: “It will be an honor for us to work with Professor Dyerberg. All Cognis products are based on sound science, which is at the heart of everything we do. So, who better to be our consultant than this pioneering scientist with unrivalled knowledge and expertise?”
The Omevital range of high purity omega-3 fatty acids is produced at the state-of-the-art facilities of Napro Pharma, now a fully-owned member of the Cognis Group. The consultancy arrangement with Cognis is inclusive of Napro Pharma and Marine Nutriceutical Corp, the group’s distribution partner in the USA for dietary supplements.
